Research project: Rapid Diagnosis of Allergy to Drugs using a Microfluidic Platform
Allergy to drugs is a category of adverse drug reaction (ADR) and affect 7%1 of the population and often result in hospitalisation. The current problem clinicians are facing is that it is difficult to diagnose drug allergy in patients as allergic mediators are often released and broken down before tests can be conducted. This is a predominant issue as false diagnosis can lead to the avoidance of a drug of choice and can lead to drugs being taken off the market. Therefore an accurate way of testing and predicting diagnosis of allergy to drugs is required.